Verition Fund Management
RCEL icon

Verition Fund Management’s Avita Medical RCEL Stock Holding History

Verition Fund Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,577
Closed -$151K – 3819
2025
Q1 		$151K Buy
18,577
+455
+3% +$4.25K ﹤0.01% 3105
2024
Q4 		$232K Buy
+18,122
New +$214K ﹤0.01% 2912
2024
Q3 		– Sell
-25,809
Closed -$204K – 3467
2024
Q2 		$204K Buy
+25,809
New +$245K ﹤0.01% 2584
2023
Q2 		– Sell
-22,287
Closed -$311K – 2475
2023
Q1 		$311K Buy
+22,287
New +$237K ﹤0.01% 1499

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Verition Fund Management's RCEL Position: Q2 2025 in Review

Verition Fund Management sold out of Avita Medical (RCEL) in Q2 2025, closing a stake of 18,577 shares — an estimated $151K sold.

Verition Fund Management first reported a position in RCEL in Q1 2023 and held it in 4 quarters. The position peaked at $311K in Q1 2023. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2025.

  • Verition Fund Management reported no remaining Avita Medical position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 18,577 Avita Medical shares in Q2 2025, an estimated $151K.
  • Verition Fund Management first reported a position in Avita Medical in Q1 2023 and held it in 4 quarters.
  • Verition Fund Management's Avita Medical position peaked at $311K in Q1 2023.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.